Delivery Order SPE2DB24D8001-SPE2DB25FLACS
- Not listed
- The Defense Logistics Agency awarded a delivery order to Dakota Drug, Inc. for Trulicity 3 mg/0.5 mL pens with a firm fixed price ceiling value of $1,345.66. The delivery order, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents pharmaceutical procurement under the DLA's medical supply operations. Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, serves as a critical vendor in the federal marketplace, specializing in...
- The Defense Logistics Agency awarded a $4,246.94 delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Trulicity 0.75 mg/0.5 mL pens. This firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and carries no set-aside designation. The award represents a specific task order placed under Dakota Drug's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a firm fixed-price delivery order valued at $1,413.68 by the Defense Logistics Agency on July 31, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. The delivery order, which carries an ultimate completion date of August 1, 2025, was issued without a set-aside designation. This award is executed under Dakota Drug's larger Indefinite Delivery Contract (IDC SPE2DB24D8001) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,312.08 to Dakota Drug, Inc. for the supply of Trulicity 4.5 mg/0.5 ml pens on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents performance at Dakota Drug's location in Anoka, Minnesota. The award falls under the company's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $2,749.16, is for the delivery of Trulicity 1.5 mg/0.5 ml pens. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT Generation V Program. This IDC allows the company to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a medication used for the treatment of diabetes. The contract has a ceiling value of $1,873.80 and is a firm fixed price delivery order with a period of performance ending on May 22, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $1,337.68, is for the delivery of Trulicity 3 mg/0.5 ml pens with a completion date of April 17, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to federal agencies, particularly the U.S. Armed Forces. The company holds a...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Trulicity 1.5 mg/0.5 ml pens. The contract has a ceiling value of $3,287.55 and a period of performance extending through March 13, 2025. Dakota Drug, Inc. is a key supplier for the DLA's medical supply chain, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that enables...
- This is a firm fixed-price delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, with a ceiling value of $1,249.83 and a completion date of July 8, 2025. The contract was awarded on July 7, 2025 by the Defense Logistics Agency (DLA), a defense agency. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,003.24 order is for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml. The award is part of Dakota Drug's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a comprehensive range of pharmaceutical...
- SPE2DB24D8001Indefinite Delivery Contract
- SPE2DB24D8001-SPE2DB25FLACSDelivery Order
The Defense Logistics Agency awarded a delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $1,162.25. This firm fixed-price delivery order was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, with no set-aside designation applied. The award falls under Dakota Drug, Inc.'s larger Indefinite Delivery Contract (SPE2DB24D8001) valued at $999,999,999.00, which is part of the DLA Troop Support Medical's ECAT Generation V Program and extends through December 31, 2025. Trulicity is a diabetes management pharmaceutical product supplied to support U.S. Armed Forces medical operations at defense healthcare facilities. Dakota Drug, Inc. has established itself as a critical pharmaceutical vendor within the federal marketplace through its long history of supplying the Defense Logistics Agency with diverse medical products including insulin, respiratory medications, pain management drugs, vaccines, and specialty therapeutics. This delivery order represents routine pharmaceutical resupply under the company's existing master contract vehicle, which authorizes the provision of comprehensive medical supplies and healthcare equipment to military healthcare facilities across the defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/29/25 |